Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 6/20 | 0.42 |
| ▸ | HSP90AB1 | P08238 | 5/20 | 0.42 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.42 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.41 |
| ▸ | CAMKK2 | Q96RR4 | 3/20 | 0.41 |
| ▸ | CHUK | O15111 | 2/20 | 0.41 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.41 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.41 |
| ▸ | INSR | P06213 | 1/20 | 0.41 |
| ▸ | SYK | P43405 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.40 |
| ▸ | FLT1 | P17948 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21100744 | 0.90 | HRH3 (0.50) | HRH3CHEK1CAMKK2CHUKMAPK8 | |
| SCHEMBL18520743 | 0.84 | LRRK2 (0.48) | HRH3CHEK1CAMKK2CHUKMAPK8 | |
| SCHEMBL18520534 | 0.84 | TNKS (0.45) | HRH3CAMKK2CHUKMAPK8LRRK2 | |
| SCHEMBL18520694 | 0.84 | LRRK2 (0.48) | HRH3HSP90AA1HSP90AB1CAMKK2CHUK | |
| SCHEMBL18520602 | 0.84 | LRRK2 (0.46) | HRH3CHEK1CAMKK2CHUKMAPK8 | |
| SCHEMBL18520762 | 0.83 | ABL1 (0.45) | HRH3CAMKK2CHUKMAPK8LRRK2 | |
| SCHEMBL18520314 | 0.82 | HRH3 (0.41) | HRH3CHEK1CAMKK2CHUKMAPK8 | |
| SCHEMBL18520742 | 0.82 | PDE2A (0.47) | HRH3CAMKK2CHUKMAPK8LRRK2 | |
| SCHEMBL18520309 | 0.81 | CAMKK2 (0.42) | HRH3HSP90AA1HSP90AB1CAMKK2CHUK | |
| SCHEMBL18520696 | 0.81 | LRRK2 (0.41) | HRH3CAMKK2CHUKMAPK8LRRK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10745356-B2 | Compositions and methods for treating tuberculosis | THE BROAD INSTITUTE, INC. (US) | 2020-08-18 | — | — | US | disclosed |
| US-20190284140-A1 | COMPOSITIONS AND METHODS FOR TREATING TUBERCULOSIS | THE BROAD INSTITUTE, INC. | 2019-09-19 | — | — | US | disclosed |
| US-10329257-B2 | Compositions and methods for treating tuberculosis | THE BROAD INSTITUTE, INC. (US) | 2019-06-25 | — | — | US | disclosed |
| WO-2017027768-A1 | COMPOSITIONS AND METHODS FOR TREATING TUBERCULOSIS | THE BROAD INSTITUTE, INC. (US) | 2017-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10745356-B2 | Compositions and methods for treating tuberculosis | C5, IFNG, TERT | HRH3 2194/4885BRD4 108/4885HSP90AA1 1264/4885 |
| US-10329257-B2 | Compositions and methods for treating tuberculosis | C5, IFNG, TERT | HRH3 2194/4885BRD4 108/4885HSP90AA1 1264/4885 |
| US-20190284140-A1 | COMPOSITIONS AND METHODS FOR TREATING TUBERCULOSIS | C5, IFNG, TERT | HRH3 2194/4885BRD4 108/4885HSP90AA1 1264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.